{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T14:32:59Z","timestamp":1794839579937,"version":"4.9.1"},"reference-count":101,"publisher":"BMJ","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:p>Drug-induced liver injury (DILI) is increasingly being recognised as a significant cause of both acute and chronic liver disease. The most commonly implicated agents are paracetamol, antimicrobials, non-steroidal anti-inflammatory drugs, statins, isoniazid and herbal remedies. Drug-induced hepatotoxicity is generally idiosyncratic in nature. The pathogenesis of DILI remains enigmatic, but involves exposure to the toxic agent, mitochondrial injury, failure of adaptation, and innate and adaptive immune responses. Diagnosis of drug-induced liver diseases can be difficult, but the key to causality is to diligently exclude other causes of liver injury, and to identify a characteristic clinical drug-related signature. Management of drug-induced liver injury is symptomatic, with early referral to a liver transplant unit at the first hint of liver failure, especially in those with non-paracetamol-induced liver injury. Prevention of drug hepatotoxicity includes increased vigilance during pre-clinical drug development and clinical trials, alanine aminotransferase monitoring with certain drugs, better marketing strategies, and the future identification of both diagnostic and prognostic biomarkers.<\/jats:p>","DOI":"10.1136\/gut.2008.163675","type":"journal-article","created":{"date-parts":[[2009,10,15]],"date-time":"2009-10-15T19:19:20Z","timestamp":1255634360000},"page":"1555-1564","source":"Crossref","is-referenced-by-count":161,"title":["Diagnosis, management and prevention of drug-induced liver injury"],"prefix":"10.1136","volume":"58","author":[{"given":"S","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Kaplowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2009,10,15]]},"reference":[{"key":"2025121222020704000_58.11.1555.1","doi-asserted-by":"crossref","unstructured":"Ostapowicz G Fontana RJ Schi\u00f8dt FV . U.S. results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Acute Liver Failure Study Group. Ann Intern Med 2002 17;137:947\u201354.","DOI":"10.7326\/0003-4819-137-12-200212170-00007"},{"key":"2025121222020704000_58.11.1555.2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2004.026005"},{"key":"2025121222020704000_58.11.1555.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.09.012"},{"key":"2025121222020704000_58.11.1555.4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20293"},{"key":"2025121222020704000_58.11.1555.5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20948"},{"key":"2025121222020704000_58.11.1555.6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/bmj.310.6973.164","article-title":"Why patients choose paracetamol for self poisoning and their knowledge of its dangers.","volume":"310","author":"Hawton","year":"1995","journal-title":"BMJ"},{"key":"2025121222020704000_58.11.1555.7","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90758-0"},{"key":"2025121222020704000_58.11.1555.8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.15.1200"},{"key":"2025121222020704000_58.11.1555.9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/j.1552-4604.1986.tb02963.x","article-title":"Outpatient drug-induced parenchymal liver disease requiring hospitalization.","volume":"26","author":"Beard","year":"1986","journal-title":"J Clin Pharmacol"},{"key":"2025121222020704000_58.11.1555.10","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.34857"},{"key":"2025121222020704000_58.11.1555.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-004-0888-z"},{"key":"2025121222020704000_58.11.1555.12","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1073117"},{"key":"2025121222020704000_58.11.1555.13","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1750"},{"key":"2025121222020704000_58.11.1555.14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.17.2215"},{"key":"2025121222020704000_58.11.1555.15","first-page":"64","article-title":"The burden of acute nonfulminant drug-induced hepatitis in a United States tertiary referral center [corrected].","volume":"39","author":"Galan","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"2025121222020704000_58.11.1555.16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21424"},{"key":"2025121222020704000_58.11.1555.17","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/gut.44.5.731","article-title":"The natural history of histologically proved drug induced liver disease.","volume":"44","author":"Aithal","year":"1999","journal-title":"Gut"},{"key":"2025121222020704000_58.11.1555.18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/hep.20445","article-title":"Drug-induced liver injury network (DILIN).","volume":"40","author":"Hoofnagle","year":"2004","journal-title":"Hepatology"},{"key":"2025121222020704000_58.11.1555.19","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.09.011"},{"key":"2025121222020704000_58.11.1555.20","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730040-00001"},{"key":"2025121222020704000_58.11.1555.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2007.06.001"},{"key":"2025121222020704000_58.11.1555.22","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfl180"},{"key":"2025121222020704000_58.11.1555.23","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M708916200"},{"key":"2025121222020704000_58.11.1555.24","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.43.100901.140229"},{"key":"2025121222020704000_58.11.1555.25","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-991513"},{"key":"2025121222020704000_58.11.1555.26","unstructured":"Liu Z Kaplowitz N . Immune mechanisms in drug-induced hepatotoxicity: Therapeutic implications in liver immunology. In: Vierling J Gershwin E , eds. Liver immunology. New Jersey: Humana Press, 2007:349\u201360."},{"key":"2025121222020704000_58.11.1555.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2004.09.002"},{"key":"2025121222020704000_58.11.1555.28","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.47.120505.105150"},{"key":"2025121222020704000_58.11.1555.29","doi-asserted-by":"publisher","DOI":"10.1086\/381446"},{"key":"2025121222020704000_58.11.1555.30","unstructured":"Pham TV . Acetaminophen hepatotoxicity, In: Taylor M, ed. Gastrointestinal emergencies. Baltimore: Williams and Wilkins, 1997:371\u201388."},{"key":"2025121222020704000_58.11.1555.31","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-0069"},{"key":"2025121222020704000_58.11.1555.32","doi-asserted-by":"crossref","unstructured":"Obermayer-Straub P Manns MP . Immunological mechanisms in liver disease. In: Kaplowitz N Deleve L , eds. Drug induced liver disease. New York: Marcel Dekker, 2003:125\u201349.","DOI":"10.1201\/9780203909126.ch7"},{"key":"2025121222020704000_58.11.1555.33","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H136"},{"key":"2025121222020704000_58.11.1555.34","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3109\/00365528109181814","article-title":"Morphologic alterations in patients with alpha-methyldopa-induced liver damage after short- and long-term exposure.","volume":"16","author":"Arranto","year":"1981","journal-title":"Scand J Gastroenterol"},{"key":"2025121222020704000_58.11.1555.35","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.149"},{"key":"2025121222020704000_58.11.1555.36","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200023040-00006"},{"key":"2025121222020704000_58.11.1555.37","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e3282f493c5"},{"key":"2025121222020704000_58.11.1555.38","doi-asserted-by":"publisher","DOI":"10.1016\/S1089-3261(02)00025-9"},{"key":"2025121222020704000_58.11.1555.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2006.05.009"},{"key":"2025121222020704000_58.11.1555.40","doi-asserted-by":"publisher","DOI":"10.1081\/DMR-120034148"},{"key":"2025121222020704000_58.11.1555.41","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840090504"},{"key":"2025121222020704000_58.11.1555.42","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01529-2"},{"key":"2025121222020704000_58.11.1555.43","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)00946-2"},{"key":"2025121222020704000_58.11.1555.44","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1365-2036.2007.03307.x","article-title":"Review article: drug hepatotoxicity.","volume":"25","author":"Chang","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"2025121222020704000_58.11.1555.45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03504.x"},{"key":"2025121222020704000_58.11.1555.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.10.021"},{"key":"2025121222020704000_58.11.1555.47","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.4.534"},{"key":"2025121222020704000_58.11.1555.48","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.1998.028s5071.x"},{"issue":"(Suppl 2)","key":"2025121222020704000_58.11.1555.49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0168-8278(97)80495-3","article-title":"Immunotoxicology of the liver: adverse reactions to drugs.","volume":"26","author":"Beaune","year":"1997","journal-title":"J Hepatol"},{"key":"2025121222020704000_58.11.1555.50","doi-asserted-by":"publisher","DOI":"10.1016\/S1089-3261(05)70022-2"},{"key":"2025121222020704000_58.11.1555.51","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.01.033"},{"key":"2025121222020704000_58.11.1555.52","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(93)90101-6"},{"key":"2025121222020704000_58.11.1555.53","unstructured":"Lucena MI Andrade RJ Camargo R . Causality assessment. In: Kaplowitz N Deleve L D , eds. Drug-induced liver disease. New York: Informa Healthcare USA, 2007:325\u2013344."},{"key":"2025121222020704000_58.11.1555.54","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22442"},{"key":"2025121222020704000_58.11.1555.55","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(90)90124-A"},{"key":"2025121222020704000_58.11.1555.56","unstructured":"Navarro V . Hepatic adverse event nomenclature document (online). Available from URL: http:\/\/www.fda.gov\/cder\/livertox\/presentations2005\/Vic_Navarro.ppt. (accessed 5 February 2009)."},{"key":"2025121222020704000_58.11.1555.57","unstructured":"Zimmerman H . Drug-induced liver disease. In: Schiff E , ed. Schiff\u2019s diseases of the liver. Baltimore: Lippincott-Raven Publishers, 1999:973\u20131064."},{"key":"2025121222020704000_58.11.1555.58","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20800"},{"key":"2025121222020704000_58.11.1555.59","unstructured":"Davidson C S Leevy C M Chamberlayne E C , eds. Guidelines for detection of hepatotoxicity due to drugs and chemicals. Forgarthy Conference, 1978. NIH publication no.:79-313. Washington, DC. National Institutes of Health, 1979."},{"key":"2025121222020704000_58.11.1555.60","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20703"},{"key":"2025121222020704000_58.11.1555.61","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70224-1"},{"key":"2025121222020704000_58.11.1555.62","doi-asserted-by":"publisher","DOI":"10.1016\/S1089-3261(05)70097-0"},{"key":"2025121222020704000_58.11.1555.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2007.11.007"},{"key":"2025121222020704000_58.11.1555.64","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm111"},{"key":"2025121222020704000_58.11.1555.65","doi-asserted-by":"publisher","DOI":"10.1007\/BF01307513"},{"key":"2025121222020704000_58.11.1555.66","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v111.pm8780577"},{"key":"2025121222020704000_58.11.1555.67","doi-asserted-by":"publisher","DOI":"10.1136\/gut.20.7.620"},{"key":"2025121222020704000_58.11.1555.68","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-985070"},{"key":"2025121222020704000_58.11.1555.69","first-page":"A79","article-title":"Intravenous N-acetylcysteine improves spontaneous survival in early stage non-acetaminophen acute liver failure [abstract].","volume":"46","author":"Lee","year":"2007","journal-title":"Hepatology"},{"key":"2025121222020704000_58.11.1555.70","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22620"},{"key":"2025121222020704000_58.11.1555.71","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22177"},{"key":"2025121222020704000_58.11.1555.72","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0016-5085(89)90081-4","article-title":"Early indicators of prognosis in fulminant hepatic failure.","volume":"97","author":"O\u2019Grady","year":"1989","journal-title":"Gastroenterology"},{"key":"2025121222020704000_58.11.1555.73","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0140-6736(02)07743-7","article-title":"Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study.","volume":"59","author":"Bernal","year":"2002","journal-title":"Lancet"},{"key":"2025121222020704000_58.11.1555.74","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20204"},{"key":"2025121222020704000_58.11.1555.75","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.1.116"},{"key":"2025121222020704000_58.11.1555.76","doi-asserted-by":"crossref","unstructured":"Maddrey WC . Drug-induced hepatotoxicity: J Clin Gastroenterol 2005;39:S83\u20139.","DOI":"10.1097\/01.mcg.0000155548.91524.6e"},{"key":"2025121222020704000_58.11.1555.77","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22895"},{"key":"2025121222020704000_58.11.1555.78","doi-asserted-by":"publisher","DOI":"10.1086\/422645"},{"key":"2025121222020704000_58.11.1555.79","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200802-355OC"},{"key":"2025121222020704000_58.11.1555.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.02.053"},{"key":"2025121222020704000_58.11.1555.81","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22536"},{"key":"2025121222020704000_58.11.1555.82","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22272"},{"key":"2025121222020704000_58.11.1555.83","doi-asserted-by":"publisher","DOI":"10.1038\/ng.379"},{"key":"2025121222020704000_58.11.1555.84","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706135"},{"key":"2025121222020704000_58.11.1555.85","unstructured":"Russo M Watkins PB . Genetic susceptibility to drug-induced liver disease. In: Kaplowitz N Deleve L D , eds. Drug-induced liver disease. New York: Informa Healthcare USA, 2007:207\u201322."},{"key":"2025121222020704000_58.11.1555.86","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20205"},{"key":"2025121222020704000_58.11.1555.87","first-page":"994","article-title":"Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis.","volume":"12","author":"Sun","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025121222020704000_58.11.1555.88","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(03)00014-6"},{"key":"2025121222020704000_58.11.1555.89","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2000.104944"},{"key":"2025121222020704000_58.11.1555.90","unstructured":"Senior J . Regulatory perspectives, In: Kaplowitz N, ed. Drug induced liver diseases. New York: Marcel Dekker, 2003:739\u201354."},{"key":"2025121222020704000_58.11.1555.91","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1212"},{"key":"2025121222020704000_58.11.1555.92","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.7.831"},{"key":"2025121222020704000_58.11.1555.93","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.11.1014"},{"key":"2025121222020704000_58.11.1555.94","first-page":"966","article-title":"Acetaminophen toxicity: changing perceptions on a social\/medical issue.","volume":"46","author":"Lee","year":"2007","journal-title":"AASLD Public Policy"},{"key":"2025121222020704000_58.11.1555.95","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730060-00002"},{"key":"2025121222020704000_58.11.1555.96","doi-asserted-by":"publisher","DOI":"10.2174\/157488606777934459"},{"key":"2025121222020704000_58.11.1555.97","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1177\/106002809202600607","article-title":"Suspected cross-reactivity of enalapril- and captopril-induced hepatotoxicity.","volume":"26","author":"Hagley","year":"1992","journal-title":"Ann Pharmacother"},{"key":"2025121222020704000_58.11.1555.98","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.295.6591.180"},{"key":"2025121222020704000_58.11.1555.99","doi-asserted-by":"publisher","DOI":"10.1007\/BF01393764"},{"key":"2025121222020704000_58.11.1555.100","first-page":"373","article-title":"Cross-hepatotoxicity between tricyclic antidepressants and phenothiazines.","volume":"7","author":"Remy","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025121222020704000_58.11.1555.101","doi-asserted-by":"publisher","DOI":"10.1136\/gut.27.6.726"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.2008.163675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:02:18Z","timestamp":1765605738000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.2008.163675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,15]]},"references-count":101,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2009,10,15]]},"published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.1136\/gut.2008.163675"],"URL":"https:\/\/doi.org\/10.1136\/gut.2008.163675","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,15]]}}}